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SUMMARY
Forty-four radical hysterectomy operations were performed between 1981 and
1986 for stage 1 cervical carcinoma. The five yearsurvival rate, (actuarial) was
84%. All deaths were directly attributable to disease recurrence. Five year
mortality was higher in those under age 45 years, and who had more than
two pregnancies. Histology and node status did not show significant correlation
with outcome. In comparison with results of radiotherapy for this condition
in Northern Ireland, (five-year survival rate 67- 6%), radical hysterectomy
produced better survival for stage I cervical carcinoma.
INTRODUCTION
In 1898 Wertheim' performed the first radical hysterectomy in Vienna whilst
Forsell2 first treated carcinoma of the cervix with radium. Since then the debate
as to which is the more appropriate treatment for cervical carcinoma has
remained unresolved. Both methods have been refined, modified and employed
either separately or in combination (Rampone3). Houston4 has recently reviewed
the results ofradiotherapy forall stagesofcervical carcinoma in Northern Ireland.
In this paper the results of radical hysterectomy for the treatment of stage 1
cervical carcinoma are presented and the two therapeutic regimens compared.
MATERIALS AND METHODS
Forty-four radical hysterectomies were performed between June 1981 and June
1986 in the Belfast City Hospital on patients clinically assessed to have stage 1
cervical carcinoma. Neither pre - nor post-operative radiotherapy was employed.
The operation consisted of removal of the uterus, cervix, a vaginal cuff of one
to two centimetres, and dissection of the parametrial tissues and pelvic nodes.
Removal of the ovaries was optional and depended largely on the age of the
patient: those under 45 years generally having one or both ovaries conserved,
those over 45 years generally having both ovaries removed. All specimens were
examined histologically at the pathology department of this hospital.
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The patients were reviewed at a joint gynaecological/oncological outpatients'
clinic. Any patients in whom recurrence was suspected were investigated
appropriately and, if necessary, treated with radiation therapy.
RESULTS
There was no operative mortality. In acute operative morbidity there were two
cases each of urinary tract infection and chest complications, five wound
abscesses and one pelvic abscess. Three instances ofureteric damage and one of
urinary retention were recorded. There were no cases of deep vein thrombosis.
No patient suffered long-term sequelae from the acute infections. The three
cases of ureteric damage were detected during operation, repaired immediately,
and no long-term complications developed.
Chronic operative morbidity included two cases of leg oedema, one of urinary
incontinence and one of coital dysfunction. No vaginal fistulae developed.
Incontinence of urine, (urgency in type), and coital dysfunction occurred in
women aged over 60 years and may notnecessarily have been related to surgery.
TABLE
Percentage survivalafterradicalhysterectomy, using variouspotentialpredicting
variables
Survived Dead
Age at treatment: (n=37) (n = 7)
< 45 years. 21 (78%) 6 (22%)
>45 years. 16 (94%) 1 ( 6%)
Parity:
<2 16 (94%) 1 ( 6%)
> 2 21 (78%) 6 (22%)
Clinical stage:
la 11 (100%) 0
1b 26 ( 78%) 7 (22%)
Node status:
Positive 3 (75%) 1 (25%)
Negative 34 (85%) 6 (15%)
Histology:
Squamous:
Differentiation
Well 1 0
Moderate 22 (82%) 5 (18%)
Poor 8 (80%) 2 (20%)
Adenocarcinoma: 5 (83%) 1 (27%)
Recurrence:
Nil 36 (100%) 0
Pelvis 1 (17%) 5 (83%)
Abdomen 0 1
Distal 0 1
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A variety ofprognostic factors isassessed against outcome in theTable. The only
clearly significant predictor isthe presence orabsence ofrecurrence atfollow -up.
Only one patient survived more than 24 months after detection of recurrence;
the majority died within one year. Only two recurrences occurred over two years
after primary surgery, and only one patient died more than three years after
primary surgery. The mean recurrence interval was 12 months and the mean
mortality interval from primary surgery 22 months. The actuarial five year
survival is 84%.
DISCUSSION
Five year survival rates for stage 1 cervical carcinoma treated by radical hyster-
ectomy have been reported by Benedet5 (81-8% of 88 patients), Powell6
(90-3% of 238 patients), and Artman7 (84-0% of 153 patients). These results
compare favourably with those reported for radiotherapy of stage 1 carcinomas
by Bygdeman8 (88-0% of 60 patients) and Hanks9 (92% of patients from a
multicentre review). Houston4 reported a 67-6% five year survival of 71 patients
with stage 1 disease treated at the Northern Ireland Radiotherapy Centre.
No cases of deep vein thrombosis occurred even though prophylactic anticoag-
ulants were not employed routinely in this series, prevention being dependent on
early mobilization. No case of vaginal fistula occurred in this series and pre-
operative radiotherapy was not used. Benedet5 showed the incidence of vaginal
fistula to be much higher in the group which received preoperative radiation
therapy than in the group which did not. The five year survival rates were not
statistically different.
In termsofprognostic factors higherage and lower parity seem to confera slightly
better prognosis which is the international experience. However nodal status and
histological gradingwereoflittle value, asalsoobserved byRommel.10Crissman11
has suggested that lymphatic and vascular space involvement in the primary
tumour is actually of greater prognostic value than confirmation of nodal
metastasis, but we did not record such involvement. The single most important
prognostic factor is recurrence: even afterpalliative radiotherapy only one patient
is alive more than two years later.
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authors recommend an aggressive approach including nutritional assessment,
biopsy, contrast radiography and endoscopy, to confirm the diagnosis in chronic
granulomatous conditionsofthemouth and todetect coincidental gastrointestinal
involvement in cases ofCrohn's disease.414 This case, where clinical assessment
was equivocal, confirms the traditional difficulties in distinguishing between
the two conditions. The evidence of malnutrition encouraged us to recommend
careful follow up and nutritional assessment. We feel it is reasonable to reserve
contrast radiology, endoscopy and biopsy for cases where specific symptoms or
nutritional assessment suggest that they are indicated. Careful clinical examin-
ation, particularly of the perianal area, is necessary in all patients with chronic
orofacial swelling.
We acknowledge the assistanceofthe DepartmentsofPathologyofAltnagelvin Hospital, Londonderry
and The Royal Victoria Hospital, Belfast.
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